We are seeking a UK‑based Site Start‑Up (SSU) Specialist to join our high‑performing and collaborative team, supporting the delivery of early‑phase clinical trials (Phase I and Phase Ib). This role plays a critical part in enabling timely study start‑up within the UK, working closely with Fortrea’s Clinical Research Unit (CRU) to drive Combined Review submissions and approvals, and ensuring studies are set up efficiently and in line with regulatory requirements. As part of a globally connected start‑up function, the role also offers the opportunity to broaden experience beyond the UK, contributing to US submissions, supporting the activation of Fortrea’s own clinical sites, and working across a wider network of research sites. This is an excellent opportunity for someone looking to deepen their expertise in UK regulatory submissions while developing within a dynamic, global start‑up environment.
Primary contact with investigative site(s) during site...